Efficacy of Xyloglucan nasal spray in allergic rhinitis childre

Phase 3

Recruiting

• Conditions: Allergic rhinitis in children; Allergic rhinitis

• Registration Number: TCTR20240318004
• Lead Sponsor: Faculty of Medicine Ramathibodi Hospital Mahidol University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2024-03-18
• Study Completion: 2024-04-26
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 80

Inclusion Criteria

1. Age 6-18 years, 2. Physician-diagnosed allergic rhinitis, 3. Aeroallergen sensitization, 4. Not pregnant, lactation

Exclusion Criteria

1. Comorbid cardiovascular disease, primary immunodeficiency, 2. Active tuberculosis, 3. Airway anomalies, 4. Current immunotherapy, 5. Recent respiratory infection in 4 weeks

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Rhinitis symptoms 2 months Total nasal symptoms score,Rhinitis symptoms 2 months Visual analogue scale (VAS),Rhinitis symptoms 2 months Peak nasal inspiratory flow(PNIF)

Secondary Outcome Measures

Name	Time	Method
Safety of Xyloglucan spray 2 months Patients report in record form